TSC2 c.1264_1265inv ;(p.S422D)

Variant ID: 16-2112504-TC-GA

NM_000548.3(TSC2):c.1264_1265inv;(p.S422D)

This variant was identified in 5 publications

View GRCh38 version.




Publications:


Antitumor activity of the dual PI3K/mTOR inhibitor gedatolisib and the involvement of ABCB1 in gedatolisib resistance in canine tumor cells.

Oncology Reports
Murase, Yusuke Y; Hosoya, Kenji K; Sato, Takachika T; Kim, Sangho S; Okumura, Masahiro M
Publication Date: 2022-04

Variant appearance in text: TSC2: S422D
PubMed Link: 35088890
Variant Present in the following documents:
  • Main text
  • or-47-04-08272.pdf
View BVdb publication page



The mTORC1/S6K1 pathway regulates glutamine metabolism through the eIF4B-dependent control of c-Myc translation.

Current Biology : Cb
Csibi, Alfredo A; Lee, Gina G; Yoon, Sang-Oh SO; Tong, Haoxuan H; Ilter, Didem D; Elia, Ilaria I; Fendt, Sarah-Maria SM; Roberts, Thomas M TM; Blenis, John J
Publication Date: 2014-10-06

Variant appearance in text: TSC2: S422D
PubMed Link: 25220053
Variant Present in the following documents:
  • Main text
View BVdb publication page



Integration of mTOR and estrogen-ERK2 signaling in lymphangioleiomyomatosis pathogenesis.

Proceedings Of The National Academy Of Sciences Of The United States Of America
Gu, Xiaoxiao X; Yu, Jane J JJ; Ilter, Didem D; Blenis, Nickolas N; Henske, Elizabeth Petri EP; Blenis, John J
Publication Date: 2013-09-10

Variant appearance in text: TSC2: S422D
PubMed Link: 23983265
Variant Present in the following documents:
  • Main text
View BVdb publication page



Development of a small-molecule serum- and glucocorticoid-regulated kinase-1 antagonist and its evaluation as a prostate cancer therapeutic.

Cancer Research
Sherk, Andrea B AB; Frigo, Daniel E DE; Schnackenberg, Christine G CG; Bray, Jeffrey D JD; Laping, Nicholas J NJ; Trizna, Walter W; Hammond, Marlys M; Patterson, Jaclyn R JR; Thompson, Scott K SK; Kazmin, Dmitri D; Norris, John D JD; McDonnell, Donald P DP
Publication Date: 2008-09-15

Variant appearance in text: TSC2: S422D
PubMed Link: 18794135
Variant Present in the following documents:
  • Main text
View BVdb publication page



The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity.

The Embo Journal
Shahbazian, David D; Roux, Philippe P PP; Mieulet, Virginie V; Cohen, Michael S MS; Raught, Brian B; Taunton, Jack J; Hershey, John W B JW; Blenis, John J; Pende, Mario M; Sonenberg, Nahum N
Publication Date: 2006-06-21

Variant appearance in text: TSC2: Ser422Asp
PubMed Link: 16763566
Variant Present in the following documents:
  • Main text
View BVdb publication page